Use of Aromatherapy on Agitation Management of Patient with Dementia

Yıl 2018, Cilt: 8 Sayı: 3, 147 - 150, 13.10.2018

Tuğçe Türten Kaymaz Leyla Özdemir

Öz

In addition to cognitive symptoms, psychiatric and behavioral symptoms such as agitation occur in the moderate and severe stage of dementia. Agitation, the most common of these symptoms, is leaded to physical, social and economic losses in the caregiver. As a result of the burden of care, the caregiver can be angry and impatient.  The results of caregiver burden increases the agitation behavior of the patient. These coercive symptoms require urgent handling and treatment of the disease. To avoid for serious and deadly side effects the use of antipsychotic drugs used in the pharmacological treatment of psychiatric and behavioral symptoms is suggested to limit in the treatment of dementia. The guides firstly suggest non-pharmacological applications for the treatment of dementia-related behavioral and psychiatric symptoms. Managing agitation behavior can help to resolve problems with the patient and caregiver, reduce the burden of care, hospitalization, and cost of illness. Aromatherapy which means treatment with fragrance, is a non-pharmacological application which used agitation management. The use of aromatherapy in agitation management in dementia patients contributes to the reduction of symptoms and caregiving burden. Increased knowledge in aromatherapy and development of evidence-based resources in the nursing literature will be affected the clinical preference of aromatherapy, its safe use, and its acceptability by the health care team. Aim of this review is to provide knowledge about use and importance of aromatherapy in dementia patients for agitation management.

Anahtar Kelimeler

Agitation, aromatherapy, dementia, nursing

Demanslı Bireylerin Ajitasyon Yönetiminde Aromaterapinin Kullanımı

Öz

Demans hastalığının orta ve ileri evrelerinde bilişsel belirtilere ek psikiyatrik ve davranışsal belirtiler ortaya çıkmaktadır. Bu belirtiler arasından en sık rastlananı olan ajitasyon, bakım verende fiziksel, sosyal ve ekonomik kayıplara yol açmaktadır. Bunun sonucu bakım yükü artan bakım veren, öfkeli, sabırsız olabilmekte, bakımdaki sonuçları ile de hastanın ajitasyon davranışı artırmaktadır. Zorlayıcı nitelikte olan bu belirtiler, hastalığın acilen ele alınmasını ve tedavisini gerektirmektedir. Psikiyatrik ve davranışsal belirtilerin farmakolojik tedavisinde kullanılan antipsikotik ilaçların, ciddi ve ölümcül yan etkilerinden korunmak için demans tedavisinde kullanımının sınırlandırılması önerilmektedir. Kılavuzlar, demansa bağlı psikiyatrik ve davranışsal belirtilerin tedavisinde öncelikle farmakolojik olmayan uygulamaların tercih edilmesini önermektedir. Ajitasyon davranışının yönetilmesi ile hastaya ve bakım verene ilişkin sorunların giderilmesi, bakım yükünün, bakımevine yatışların ve hastalık maliyetinin azalması sağlanabilir. Koku ile tedavi anlamına gelen aromaterapi, ajitasyon yönetiminde kullanılan farmakolojik olmayan uygulamalar arasında yer almaktadır. Demans hastalarında ajitasyon yönetiminde aromaterapinin kullanımı, semptomların ve bakım veren yükünün azaltılmasına katkı sağlamaktadır. Aromaterapi konusunda bilgi ve deneyim artışı, hemşirelik literatüründe kanıt temelli kaynakların gelişimi, aromaterapinin klinikte tercih edilirliğini, güvenli kullanımını ve sağlık ekibi tarafından kabul edilirliğini etkileyecektir. Bu derlemede, demans hastasında ajitasyon yönetiminde aromaterapinin kullanımı ve önemi hakkında bilgi sağlamak amaçlanmıştır.

Anahtar Kelimeler

Ajitasyon, aromaterapi, demans, hemşirelik

Kaynakça

• 1. Eker E. Alzheimer hastalığı. İÜ Cerrahpaşa Tıp Fakültesi sürekli tıp eğitimi etkinlikleri, Türkiye’de sık karşılaşılan psikiyatrik hastalıklar sempozyum dizisi. 2008;62:85-110.2. Selekler K. Alzheimer ve diğer demanslar (Modern Tıp Seminerleri: 26). Ankara: Güneş Kitabevi Yayınları; 2003.3. Emilien G, Durlac C, Minaker KL, Winbled B, Gauthier S, Moloteaux JM, editor. Alzheimer Hastalığı: Nöropsikoloji ve farmakoloji. İstanbul: Global Publishing; 2005.4. Khoo SA, Chen TY, Ang YH, Yap P. The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic. Int Psychogeriatr. 2013;25(12):1991-9.5. Meziere A, Blachier M, Thomas S, Verny M, Herbaud S, Bouillanne O, et al. Neuropsychiatric symptoms in elderly inpatients: a multicenter cross-sectional study. Dement Geriatr Cogn Dis Extra. 2013;3(1):123-30.6. Sadak TI, Katon J, Beck C, Cochrane BB, Borson S. Key neuropsychiatric symptoms in common dementias: Prevalence and implications for caregivers, clinicians, and health systems. Res Gerontol Nurs. 2014;7(1):44-52.7. Hendriks SA, Smalbrugge M, Hertogh CM, van der Steen JT. Dying with dementia: Symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage. 2014;47(4):710-20.8. Cummings JF. Alzheimer Hastalığı ve İlişkili Demansların Nöropskiyatrik Özellikleri. B M, editor. Istanbul: Sigma Publishing; 2007.9. Cohen-Mansfield J. Conceptualization of agitation: Results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument. Int Psychogeriatr. 1996;8 Suppl 3:309-15.10. Donaldson C, Burns A. Burden of Alzheimer's disease: Helping the patient and caregiver. J Geriatr Psychiatry Neurol. 1999;12(1):21-8.11. Erder MH, Wilcox TK, Chen WH, O'Quinn S, Setyawan J, Saxton J. A new measure of caregiver burden in Alzheimer's disease: The caregiver-perceived burden questionnaire. Am J Alzheimers Dis Other Demen. 2012;27(7):474-82.12. Gaugler JE, Wall MM, Kane RL, Menk JS, Sarsour K, Johnston JA, et al. Does caregiver burden mediate the effects of behavioral disturbances on nursing home admission? The Am J Geriatr Psychiatry. 2011;19(6):497-506.13. Wilcock GK, Ballard CG, Cooper JA, Loft H. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies. J Clin Psychiatry. 2008;69(3):341-8.14. Trifiro G, Spina E, Gambassi G. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? Pharmacol Res. 2009;59(1):1-12.15. NICE Clinical Guideline 42: Dementia; Supporting People with Dementia and Their Carers in Health and Social Care 2006. https://www.nice.org.uk/guidance/cg42 (Erişim Tarihi: 15.03.2016).16. SIGN National Guideline. Manegement of Patients with Dementia 2006. http://www.sign.ac.uk (Erişim Tarihi: 15.03.2016).17. Uluslararası Psikogeriatri Derneği. Behavioral and Psychological Symptoms of Dementia-Specialists Guide. www.ipa-online.org2016 (Erişim Tarihi: 15.03.2016).18. Buckle J. Clinical Aromatherapy: Essential Oils in Practice. London: Elseiver; 2015.19. Micozzi MS. Fundamentals of Complementary and Alternative Medicine. U.S.A: Saunders Elseiver; 2015.20. O'Connor DW, Eppingstall B, Taffe J, van der Ploeg ES. A randomized, controlled cross-over trial of dermally-applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia. BMC Complement Altern Med. 2013;13:315.21. Fu CY, Moyle W, Cooke M. A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behaviour in people with dementia. BMC Complement Altern Med. 2013;13:165-73.22. Fujii M, Hatakeyama R, Fukuoka Y, Yamamoto T, Sasaki R, Moriya M, et al. Lavender aroma therapy for behavioral and psychological symptoms in dementia patients. Geriatr Gerontol Int. 2008;8(2):136-8.23. Lin PW, Chan WC, Ng BF, Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: A cross-over randomized trial. Int J Geriatr Psychiatry. 2007;22(5):405-10.24. Blanco MM, Costa CA, Freire AO, Santos JG, Jr., Costa M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine. 2009;16(2-3):265-70.25. Costa CA, Kohn DO, de Lima VM, Gargano AC, Florio JC, Costa M. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass). J Ethnopharmacol. 2011;137(1):828-36.26. Goes TC, Ursulino FR, Almeida-Souza TH, Alves PB, Teixeira-Silva F. Effect of lemongrass aroma on experimental anxiety in humans. J Altern Complement Med. 2015;21(12):766-73.27. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry. 2002;63(7):553-8.28. Yang MH, Lin LC, Wu SC, Chiu JH, Wang PN, Lin JG. Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation. BMC Complement Altern Med. 2015;15:93.29. Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges. Am J Alzheimers Dis Other Demen. 2002;17(3):169-74.30. Snow LA, Hovanec L, Brandt J. A controlled trial of aromatherapy for agitation in nursing home patients with dementia. J Altern Complement Med. 2004;10(3):431-7.31. Joswiak D, Kinney ME, Johnson JR, Kolste AK, Griffin KH, Rivard RL, et al. Development of a Health system-based nurse-delivered aromatherapy program. J Nurs Adm. 2016;46(4):221-5.32. Turan N. Ö, A., Kaya, N. Hemşirelikte yeni bir sorumluluk alanı: Tamamlayıcı terapi. Maltepe Üniversitesi Hemşirelik Bilim ve Sanatı Dergisi. 2010;3(1):103-8.33. Cole A, Shanley E. Complementary therapies as a means of developing the scope of professional nursing practice. J Adv Nurs. 1998;27(6):1171-6.34. Johannessen B. Nurses experience of aromatherapy use with dementia patients experiencing disturbed sleep patterns. An action research project. Complement Ther Clin Pract. 2013;19(4):209-13.35. DeKeyser FG, Bar Cohen B, Wagner N. Knowledge levels and attitudes of staff nurses in Israel towards complementary and alternative medicine. J Adv Nurs. 2001;36(1):41-8.36. Maddocks-Jennings W, Wilkinson JM. Aromatherapy practice in nursing: Literature review. J Adv Nurs. 2004;48(1):93-103.